Intervet/Schering-Plough: New Vaccine, High Payback

by 5m Editor
12 September 2008, at 11:30am

UK - Porcilis® COLI 6C, a sow vaccine developed to protect piglets against E. coli and Clostridium perfringens via antibodies in the colostrum, has been added to Intervet / Schering Plough's range of pig vaccines.

The new vaccine provides broad protection against these pathogens which are frequently found in outdoor and straw based pig production systems.

The formulation of Porcilis® COLI 6C is identical to that of GLETVAX® 6, a vaccine that was recently acquired by Pfizer from Schering-Plough as part of a product divestiture programme. Like its forerunner, sows only require a single booster dose of the new Porcilis® vaccine, which makes it simple for farmers to incorporate this new product into their existing vaccination programmes. Incoming gilts and previously non-vaccinated sows will require two doses of the vaccine for the primary course.

John Richardson of Intervet / Schering Plough says that the new vaccine is a very useful addition to the comprehensive Porcilis® range.

"The loss of a single pig due to E.coli or Clostridial scours is equal to the cost of protecting 146 pigs by the vaccination of just 13 sows. So the strategy of using this vaccine does offer a very high payback on investment," he adds.

Porcilis® COLI 6C is available from pig veterinarians and animal health product retailers. It is supplied in 50 ml vials (10 doses) and can be easily and accurately administered using Intervet / Schering Plough's high-quality, automatic, vial-mounted 5ml fixed dose vaccination gun.